| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.3B | $0.1B | $0.5B | $1.0B | $1.6B | $0.2B | $0.0B |
| EPS (Basic) | $9.69 | $6.11 | $2.89 | $8.96 | $15.73 | $21.91 | $1.95 | $0.65 |
| EPS (Diluted) | $9.30 | $5.84 | $2.74 | $8.50 | $14.87 | $20.92 | $1.88 | $0.63 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.4B | $26.1B | $18.8B | $16.8B | $18.8B | $31.6B | $10.2B | $7.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.2B | $0.9B | $1.3B | $0.3B | $0.5B | $0.2B | $0.2B |
| Total Liabilities | $25.1B | $22.3B | $15.3B | $13.4B | $15.4B | $28.2B | $8.1B | $5.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | — | — | — | — | — | — | — | $1.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-1.7B | $-4.5B | $-1.6B | $6.0B | $2.6B | $-6.2B | $-2.2B | $0.6B |
| Investing Cash Flow | $0.6B | $-1.9B | $-0.3B | $-0.7B | $-0.3B | $0.8B | $0.1B | $-0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $1.2B | $5.7B | $1.5B | $-4.3B | $-2.5B | $5.8B | $2.1B | $-0.1B |